OSTROV; David A.
Patent Applications and Registrations
Patent applications and USPTO patent grants for OSTROV; David A..The latest application filed is for "method of treating colorectal cancers using a pkc inhibitor".
Company Profile
1.29.29
- OSTROV; David A. - Gainesville FL
- Ostrov; David A. - Gainesvill e FL
Patent Activity
| Patent | Date |
|---|---|
| Method of Treating Colorectal Cancers Using a PKC Inhibitor App 20220241226 - ACEVEDO-DUNCAN; Mildred ; et al. | 2022-08-04 |
| Method of treating colorectal cancers using a PKC inhibitor Grant 11,337,944 - Acevedo-Duncan , et al. May 24, 2 | 2022-05-24 |
| Method of treating melanoma using an inhibitor of an atypical protein kinase C Grant 11,065,266 - Acevedo-Duncan , et al. July 20, 2 | 2021-07-20 |
| Enhancers of Neurolysin Activity App 20210198647 - Karamyan; Vardan T. ; et al. | 2021-07-01 |
| Method of treating melanoma using an inhibitor of an atypical protein kinase C Grant 10,918,650 - Acevedo-Duncan , et al. February 16, 2 | 2021-02-16 |
| Method of Treating Melanoma Using an Inhibitor of an Atypical Protein Kinase C App 20200022994 - ACEVEDO-DUNCAN; Mildred Enid ; et al. | 2020-01-23 |
| Drug targets to overcome de novo drug-resistance in multiple myeloma Grant 9,616,051 - Sullivan , et al. April 11, 2 | 2017-04-11 |
| Therapeutic combinations for use in neoplasia Grant 9,517,244 - Narayan , et al. December 13, 2 | 2016-12-13 |
| Use of PKC-iota inhibitors for the treatment of breast cancer Grant 9,351,981 - Acevedo-Duncan , et al. May 31, 2 | 2016-05-31 |
| Use Of Pkc-iota Inhibitors For The Treatment Of Breast Cancer App 20160106767 - Acevedo-Duncan; Mildred Enid ; et al. | 2016-04-21 |
| Compositions and methods of treating neoplasia Grant 9,144,596 - Narayan , et al. September 29, 2 | 2015-09-29 |
| Therapeutic combinations for use in neoplasia Grant 8,815,828 - Narayan , et al. August 26, 2 | 2014-08-26 |
| Nuclear export inhibitors of topoisomerase II alpha Grant 8,623,854 - Sullivan , et al. January 7, 2 | 2014-01-07 |
| Cyclin dependent kinase inhibitors Grant 8,569,356 - Ostrov , et al. October 29, 2 | 2013-10-29 |
| Novel Drug Targets To Overcome De Novo Drug-resistance In Multiple Myeloma App 20130281389 - Sullivan; Daniel M. ; et al. | 2013-10-24 |
| Methods and compositions for the treatment of cancers and pathogenic infections Grant 8,545,841 - Dunn , et al. October 1, 2 | 2013-10-01 |
| Methods and compositions for treating neoplasia Grant 8,501,242 - Ostrov , et al. August 6, 2 | 2013-08-06 |
| Use Of Pkc-iota Inhibitors For The Treatment Of Breast Cancer App 20130189257 - Acevedo-Duncan; Mildred Enid ; et al. | 2013-07-25 |
| PDK inhibitor compounds and methods of use thereof Grant 8,492,344 - Ostrov , et al. July 23, 2 | 2013-07-23 |
| Methods And Compositions For Treating Ace2-related Disorders App 20130165417 - Raizada; Mohan K. ; et al. | 2013-06-27 |
| Method of selectively inhibiting PKCiota Grant 8,461,192 - Acevedo-Duncan , et al. June 11, 2 | 2013-06-11 |
| Compounds and methods for treatment of alpha-1 antitrypsin deficiency Grant 8,436,013 - Liu , et al. May 7, 2 | 2013-05-07 |
| Kinase Protein Binding Inhibitors App 20130079297 - Cance; William G. ; et al. | 2013-03-28 |
| Kinase modulating compounds and uses thereof for treatment of cancer Grant 8,404,669 - Cance , et al. March 26, 2 | 2013-03-26 |
| Kinase protein binding inhibitors Grant 8,314,150 - Cance , et al. November 20, 2 | 2012-11-20 |
| Methods And Compositions For Treating Neoplasia App 20120156212 - Ostrov; David A. ; et al. | 2012-06-21 |
| Ace2 Activator Compounds And Methods Of Use Thereof App 20120142723 - Ostrov; David A. ; et al. | 2012-06-07 |
| Kinase Protein Binding Inhibitors App 20120107323 - Hochwald; Steven N. ; et al. | 2012-05-03 |
| Kinase Protein Binding Inhibitors App 20120100227 - Golubovskaya; Vita ; et al. | 2012-04-26 |
| Methods For Treating Osteoclast-related Disease, Compounds And Compositions Thereof App 20120046246 - Holliday; Lexie Shannon ; et al. | 2012-02-23 |
| Pdk Inhibitor Compounds And Methods Of Use Thereof App 20120004284 - Ostrov; David A. ; et al. | 2012-01-05 |
| Nuclear Export Inhibitors Of Topoisomerase Ii Alpha App 20110275581 - Sullivan; Daniel M. ; et al. | 2011-11-10 |
| Ant4 Inhibitor Compounds And Methods Of Use Thereof App 20110230564 - Terada; Naohiro ; et al. | 2011-09-22 |
| Therapeutic Combinations For Use In Neoplasia App 20110152206 - Narayan; Satya ; et al. | 2011-06-23 |
| Compositions And Methods For The Treatment Of Neoplasia App 20110110958 - Qiu; Jingxin ; et al. | 2011-05-12 |
| Kinase Protein Binding Inhibitors App 20110065664 - Cance; William G. ; et al. | 2011-03-17 |
| Methods And Compositions For The Treatment Of Cancers And Pathogenic Infections App 20100285012 - Dunn, JR.; William A. ; et al. | 2010-11-11 |
| Compositions and Methods of Treating Neoplasia App 20100190702 - Narayan; Satya ; et al. | 2010-07-29 |
| Compounds and Methods for Treatment of Alpha-1 Antitrypsin Deficiency App 20100076018 - Liu; Chen ; et al. | 2010-03-25 |
| Cyclin Dependent Kinase Inhibitors App 20100035940 - Ostrov; David A. ; et al. | 2010-02-11 |
| Opsin Stabilizing Compounds and Methods of Use App 20090286808 - Kaushal; Shalesh ; et al. | 2009-11-19 |
| Kinase protein binding inhibitors App 20090239850 - Cance; William G. ; et al. | 2009-09-24 |
| METHOD OF SELECTIVELY INHIBITING PKCiota App 20090075932 - Acevedo-Duncan; Mildred ; et al. | 2009-03-19 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 